Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Consulting agrmnt
Quarterly results

AFFYMAX INC (AFFY) Create: Alert

All | News | Filings
Date FiledTypeDescription
09/24/2014 8-K Quarterly results
09/19/2014 SC 13D/A COUCHMAN JONATHAN reports a 5% stake in Affymax, Inc.
09/09/2014 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
08/25/2014 SC 13D/A COUCHMAN JONATHAN reports a 5% stake in Affymax, Inc.
08/22/2014 SC 13D COUCHMAN JONATHAN reports a 5% stake in Affymax, Inc.
08/18/2014 DEF 14A Form DEF 14A - Other definitive proxy statements
08/06/2014 DEF 14A Form DEF 14A - Other definitive proxy statements
07/31/2014 10-Q Quarterly Report for the period ended June 30, 2014
07/17/2014 8-K Other Events, Financial Statements and Exhibits
Docs: "EX - 99.1",
"EX - 99.2"
06/24/2014 8-K Other Events, Financial Statements and Exhibits
Docs: "Limited Continuation of Company"
06/13/2014 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "Affymax and Takeda Announce Termination of OMONTYS® (peginesatide) Product Collaboration and License Agreement"
05/14/2014 8-K Other Events
05/06/2014 10-Q Quarterly Report for the period ended March 31, 2014
04/30/2014 DEF 14A Form DEF 14A - Other definitive proxy statements
03/31/2014 10-K Annual Report for the period ended December 31, 2013
02/14/2014 SC 13G/A Visium Asset Management, LP reports a 0% stake in Affymax, Inc.
02/13/2014 SC 13G/A ORBIMED ADVISORS LLC reports a 1% stake in Affymax, Inc.
02/10/2014 SC 13G/A VANGUARD GROUP INC reports a 13% stake in Affymax Inc
02/06/2014 SC 13G/A OppenheimerFunds, Inc. reports a 0% stake in AFFYMAX, INC.
11/12/2013 10-Q/A Quarterly Report for the period ended September 30, 2013 [amend]
11/12/2013 10-Q/A Quarterly Report for the period ended June 30, 2013 [amend]
11/05/2013 10-Q Quarterly Report for the period ended September 30, 2013
08/29/2013 4 WALKER JOHN PETER (Director) has filed a Form 4 on AFFYMAX INC
Txns: Sold 16,040 shares @ $1.92, valued at $30.8k
Sold 500 shares @ $1.928, valued at $964
08/20/2013 8-K Form 8-K - Current report
08/02/2013 10-Q Quarterly Report for the period ended June 30, 2013
07/19/2013 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
07/10/2013 SC 13G/A BlackRock Inc. reports a 0.5% stake in AFFYMAX INC.
06/28/2013 4 Orwin John A (Director) has filed a Form 4 on AFFYMAX INC
Txns: Paid exercise price by delivering 16,334 shares @ $1.0225, valued at $16.7k
Gifted 15,000 shares @ $0
06/10/2013 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
06/07/2013 8-K Entered into consulting agreement
05/09/2013 10-Q Quarterly Report for the period ended March 31, 2013
05/02/2013 ARS Form ARS - Annual Report to Security Holders
04/29/2013 DEF 14A Form DEF 14A - Other definitive proxy statements
04/23/2013 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy